Application
一种有效的EZH2抑制剂,作用于PRC2时,IC50<1nM。
CPI-169 is a potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2). CPI-169 was shown to inhibit tumor growth in a NHL xenograft model, reducing global H3K27me3.1 It has also been shown to synergize with the B-cell lymphoma inhibitor, ABT-199, to suppress the growth of NHL cell lines。
CPI-169是有效的zeste同源物2(EZH2)增强剂,对多梳抑制复合物2(PRC2)的IC50值<1nM。 CPI-169在NHL异种移植模型中显示出抑制肿瘤生长的作用,从而降低了整体H3K27me3.1的水平。它还显示出与B细胞淋巴瘤抑制剂ABT-199的协同作用,从而抑制了NHL细胞系的生长。
安全信息
RIDADR NONH for all modes of transport